Marked Sinus Bradycardia Associated With Remdesivir in COVID-19
James C. Gubitosa, Parul Kakar, Christine Gerula, Hernando Nossa, Diana Finkel, Kristin Wong, Megna Khatri, Hasan Ali
Abstract
Remdesivir has seen extensive use during the coronavirus disease-2019 pandemic given its clinically proven efficacy against severe acute respiratory syndrome coronavirus type 2. There has been little cited regarding adverse effects. Here we present the case of a patient with marked sinus bradycardia that began acutely on initiation of remdesivir and resolved almost immediately on cessation of the drug. (Level of Difficulty: Beginner.)
Topics & Concepts
BradycardiaMedicineCoronavirus disease 2019 (COVID-19)PandemicSinus bradycardiaCoronavirus2019-20 coronavirus outbreakSinus (botany)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AnesthesiaAdverse effectIntensive care medicineInternal medicineDiseaseVirologyHeart rateInfectious disease (medical specialty)Blood pressureOutbreakGenusBotanyBiologyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and Thrombosis